FEDERAL Health Minister, Greg Hunt, has today announced immunotherapy, Imfinzi (durvalumab) will be listed on the Pharmaceutical Benefits Scheme (PBS) for the treatment of lung cancer from 01 Mar.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Feb 20
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Feb 20